Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.439, 2003-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Levothyroxine plus liothyronine no aid to QOL in hypothyroidism
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :
Access to resources
Recommend
Levothyroxine plus liothyronine no aid to QOL in hypothyroidism
Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. :
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Imatinib mesylate confers large QOL benefit in CML
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. :
Fluoxetine affords QOL benefit in advanced cancer, depression
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. :